Skip to Main Content

Paper Details

N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
J Clin Invest
111
2019
AR, AR-, EZH2, FOXA1, HOXB13, N, N-Myc, NEPC, NEPC tumors, advanced prostate cancer, androgen, androgen receptor, cancer, castration resistant prostate cancers, cistrome, epithelial lineage genes, genomic loci, lineage-defining genes, neural, neural lineage, neuroendocrine prostate cancer, patient, patient-derived organoids, patients, prostate cancer
Author NameAffiliation
Rohan BarejaCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Brian D Robinson
Brian D RobinsonCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Loredana Puca
Andrea Sboner
Andrea SbonerMeyer Cancer Center
Andrea SbonerInstitute for Computational Biomedicine
Andrea SbonerCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Andrea Sboner
Andrea SbonerCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Andrea SbonerInstitute for Computational Biomedicine
Andrea SbonerMeyer Cancer Center
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Olivier ElementoMeyer Cancer Center
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoMeyer Cancer Center
Christopher E BarbieriCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Christopher E BarbieriMeyer Cancer Center
Christopher E Barbieri
Christopher E BarbieriCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Christopher E Barbieri
Christopher E BarbieriMeyer Cancer Center
Himisha BeltranCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Himisha BeltranDana-Farber Cancer Institute
Himisha Beltran
Himisha BeltranCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
Himisha Beltran
Himisha BeltranDana-Farber Cancer Institute
David S Rickman
David S RickmanCaryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.
David S RickmanMeyer Cancer Center
  • 1 - 33

Datasets

Release 1.2